Hmdb loader

HMDBP02173 (Peroxisome proliferator-activated receptor gamma) Metabolite Associations

Displaying metabolite protein links 26 - 50 of 54 in total
HMDB ID Name CAS NumberStructureFormula Average Mass
Monoisotopic Mass 		References
HMDB0003712(2E)-Dodecenoyl-CoA1066-12-2ThumbC33H56N7O17P3S947.82
947.266625539		Not Available
HMDB0003944trans-2-Hexenoyl-CoA10018-93-6ThumbC27H44N7O17P3S863.661
863.172723243		Not Available
HMDB0003945(2E)-Hexadecenoyl-CoA4460-95-1ThumbC37H64N7O17P3S1003.93
1003.329225797		Not Available
HMDB0003946(2E)-Tetradecenoyl-CoA38795-33-4ThumbC35H60N7O17P3S975.874
975.297923755		Not Available
HMDB0003948(2E)-Decenoyl-CoA10018-95-8ThumbC31H52N7O17P3S919.768
919.235323499		Not Available
HMDB0003949(2E)-Octenoyl-CoA10018-94-7ThumbC29H48N7O17P3S891.714
891.204023371		Not Available
HMDB00042573Z-dodecenoyl-CoA2152-91-2ThumbC33H56N7O17P3S947.821
947.266623627		Not Available
HMDB0004258Eicosanoyl-CoA15895-27-9ThumbC41H74N7O17P3S1062.06
1061.407476119		Not Available
HMDB0005006Atorvastatin134523-00-5ThumbC33H35FN2O5558.6398
558.253000445		Not Available
HMDB0005031Rosiglitazone122320-73-4ThumbC18H19N3O3S357.427
357.114712179		Not Available
HMDB0006404Decanoyl-CoA (n-C10:0CoA)1264-57-9ThumbC31H54N7O17P3S921.783
921.250973563		Not Available
HMDB0006497Heptadecanoyl CoA3546-17-6ThumbC38H68N7O17P3S1019.97
1019.360524011		Not Available
HMDB0006526Tetracosanoyl-CoAThumbC45H82N7O17P3S1118.156
1117.470074459		Not Available
HMDB0006529trans-Octadec-2-enoyl-CoAThumbC39H68N7O17P3S1031.98
1031.360524011		Not Available
HMDB00116602-Methylhexanoyl-CoAThumbC28H48N7O17P3S879.704
879.204023371		Not Available
HMDB0012969Heptanoyl-CoAThumbC28H48N7O17P3S879.704
879.204023371		Not Available
HMDB0013028Nonanoyl-CoA17331-98-5ThumbC30H52N7O17P3S907.757
907.235323499		Not Available
HMDB0013037Pentanoyl-CoAThumbC26H44N7O17P3S851.651
851.172723243		Not Available
HMDB0013114Undecanoyl-CoAThumbC32H56N7O17P3S935.81
935.266623627		Not Available
HMDB0014389Mesalazine89-57-6ThumbC7H7NO3153.1354
153.042593095
  1. Rousseaux C, Lefebvre B, Dubuquoy L, Lefebvre P, Romano O, Auwerx J, Metzger D, Wahli W, Desvergne B, Naccari GC, Chavatte P, Farce A, Bulois P, Cortot A, Colombel JF, Desreumaux P: Intestinal antiinflammatory effect of 5-aminosalicylic acid is dependent on peroxisome proliferator-activated receptor-gamma. J Exp Med. 2005 Apr 18;201(8):1205-15. Epub 2005 Apr 11. [PubMed:15824083 ]
  2. Schwab M, Reynders V, Loitsch S, Shastri YM, Steinhilber D, Schroder O, Stein J: PPARgamma is involved in mesalazine-mediated induction of apoptosis and inhibition of cell growth in colon cancer cells. Carcinogenesis. 2008 Jul;29(7):1407-14. doi: 10.1093/carcin/bgn118. Epub 2008 Jun 9. [PubMed:18544567 ]
  3. Linard C, Gremy O, Benderitter M: Reduction of peroxisome proliferation-activated receptor gamma expression by gamma-irradiation as a mechanism contributing to inflammatory response in rat colon: modulation by the 5-aminosalicylic acid agonist. J Pharmacol Exp Ther. 2008 Mar;324(3):911-20. Epub 2007 Dec 12. [PubMed:18077625 ]
  4. Desreumaux P, Ghosh S: Review article: mode of action and delivery of 5-aminosalicylic acid - new evidence. Aliment Pharmacol Ther. 2006 Sep;24 Suppl 1:2-9. [PubMed:16939423 ]
HMDB0014869Nateglinide105816-04-4ThumbC19H27NO3317.4226
317.199093735
  1. Scarsi M, Podvinec M, Roth A, Hug H, Kersten S, Albrecht H, Schwede T, Meyer UA, Rucker C: Sulfonylureas and glinides exhibit peroxisome proliferator-activated receptor gamma activity: a combined virtual screening and biological assay approach. Mol Pharmacol. 2007 Feb;71(2):398-406. Epub 2006 Nov 2. [PubMed:17082235 ]
HMDB0014933Sulfasalazine599-79-1ThumbC18H14N4O5S398.393
398.068490268
  1. Rousseaux C, Lefebvre B, Dubuquoy L, Lefebvre P, Romano O, Auwerx J, Metzger D, Wahli W, Desvergne B, Naccari GC, Chavatte P, Farce A, Bulois P, Cortot A, Colombel JF, Desreumaux P: Intestinal antiinflammatory effect of 5-aminosalicylic acid is dependent on peroxisome proliferator-activated receptor-gamma. J Exp Med. 2005 Apr 18;201(8):1205-15. Epub 2005 Apr 11. [PubMed:15824083 ]
  2. Schwab M, Reynders V, Loitsch S, Shastri YM, Steinhilber D, Schroder O, Stein J: PPARgamma is involved in mesalazine-mediated induction of apoptosis and inhibition of cell growth in colon cancer cells. Carcinogenesis. 2008 Jul;29(7):1407-14. doi: 10.1093/carcin/bgn118. Epub 2008 Jun 9. [PubMed:18544567 ]
  3. Linard C, Gremy O, Benderitter M: Reduction of peroxisome proliferation-activated receptor gamma expression by gamma-irradiation as a mechanism contributing to inflammatory response in rat colon: modulation by the 5-aminosalicylic acid agonist. J Pharmacol Exp Ther. 2008 Mar;324(3):911-20. Epub 2007 Dec 12. [PubMed:18077625 ]
  4. Desreumaux P, Ghosh S: Review article: mode of action and delivery of 5-aminosalicylic acid - new evidence. Aliment Pharmacol Ther. 2006 Sep;24 Suppl 1:2-9. [PubMed:16939423 ]
HMDB0015048Repaglinide135062-02-1ThumbC27H36N2O4452.5857
452.26750765
  1. Scarsi M, Podvinec M, Roth A, Hug H, Kersten S, Albrecht H, Schwede T, Meyer UA, Rucker C: Sulfonylureas and glinides exhibit peroxisome proliferator-activated receptor gamma activity: a combined virtual screening and biological assay approach. Mol Pharmacol. 2007 Feb;71(2):398-406. Epub 2006 Nov 2. [PubMed:17082235 ]
HMDB0015101Telmisartan144701-48-4ThumbC33H30N4O2514.6169
514.236876224
  1. Tagami T, Yamamoto H, Moriyama K, Sawai K, Usui T, Shimatsu A, Naruse M: A selective peroxisome proliferator-activated receptor-gamma modulator, telmisartan, binds to the receptor in a different fashion from thiazolidinediones. Endocrinology. 2009 Feb;150(2):862-70. doi: 10.1210/en.2008-0502. Epub 2009 Jan 15. [PubMed:19147680 ]
  2. Imayama I, Ichiki T, Inanaga K, Ohtsubo H, Fukuyama K, Ono H, Hashiguchi Y, Sunagawa K: Telmisartan downregulates angiotensin II type 1 receptor through activation of peroxisome proliferator-activated receptor gamma. Cardiovasc Res. 2006 Oct 1;72(1):184-90. Epub 2006 Jul 21. [PubMed:16938288 ]
  3. Kurtz TW: Beyond the classic angiotensin-receptor-blocker profile. Nat Clin Pract Cardiovasc Med. 2008 Jul;5 Suppl 1:S19-26. doi: 10.1038/ncpcardio0805. [PubMed:18580862 ]
  4. Yamagishi S, Takeuchi M: Telmisartan is a promising cardiometabolic sartan due to its unique PPAR-gamma-inducing property. Med Hypotheses. 2005;64(3):476-8. [PubMed:15617852 ]
  5. Yamagishi S, Nakamura K, Matsui T: Potential utility of telmisartan, an angiotensin II type 1 receptor blocker with peroxisome proliferator-activated receptor-gamma (PPAR-gamma)-modulating activity for the treatment of cardiometabolic disorders. Curr Mol Med. 2007 Aug;7(5):463-9. [PubMed:17691961 ]
  6. Kurtz TW: Treating the metabolic syndrome: telmisartan as a peroxisome proliferator-activated receptor-gamma activator. Acta Diabetol. 2005 Apr;42 Suppl 1:S9-16. [PubMed:15868121 ]
  7. Yamagishi S, Takenaka K, Inoue H: Role of insulin-sensitizing property of telmisartan, a commercially available angiotensin II type 1 receptor blocker in preventing the development of atrial fibrillation. Med Hypotheses. 2006;66(1):118-20. Epub 2005 Sep 12. [PubMed:16154710 ]
HMDB0015149Balsalazide80573-04-2ThumbC17H15N3O6357.3175
357.096085227
  1. Linard C, Gremy O, Benderitter M: Reduction of peroxisome proliferation-activated receptor gamma expression by gamma-irradiation as a mechanism contributing to inflammatory response in rat colon: modulation by the 5-aminosalicylic acid agonist. J Pharmacol Exp Ther. 2008 Mar;324(3):911-20. Epub 2007 Dec 12. [PubMed:18077625 ]
  2. Desreumaux P, Ghosh S: Review article: mode of action and delivery of 5-aminosalicylic acid - new evidence. Aliment Pharmacol Ther. 2006 Sep;24 Suppl 1:2-9. [PubMed:16939423 ]
  3. Tursi A: Balsalazide in treating colonic diseases. Expert Opin Drug Metab Toxicol. 2009 Dec;5(12):1555-63. doi: 10.1517/17425250903228842. [PubMed:19708827 ]
  4. Iacucci M, de Silva S, Ghosh S: Mesalazine in inflammatory bowel disease: a trendy topic once again? Can J Gastroenterol. 2010 Feb;24(2):127-33. [PubMed:20151072 ]
Displaying metabolite protein links 26 - 50 of 54 in total